Back to Search
Start Over
Treatment of early Parkinson's disease. Part 2.
- Source :
-
European neurology [Eur Neurol] 2009; Vol. 61 (4), pp. 206-15. Date of Electronic Publication: 2009 Jan 29. - Publication Year :
- 2009
-
Abstract
- The management of early Parkinson's disease (PD) involves the treatment of motor symptoms, and, increasingly, non-motor symptoms. Given the fast pace of clinical research in PD, clinicians are faced with the challenge of integrating the latest findings into the ongoing care of individual PD patients. Part 1 of this 2-part article reviews efficacy and safety data for the newest PD treatment options, as well as for established therapies. Part 2 of the article, presented here, reviews key data relevant to the assessment of potential neuroprotective therapies and the treatment of non-motor symptoms.<br /> (Copyright 2009 S. Karger AG, Basel.)
- Subjects :
- Autonomic Nervous System Diseases drug therapy
Clinical Trials as Topic
Cognition Disorders drug therapy
Depression drug therapy
Disruptive, Impulse Control, and Conduct Disorders drug therapy
Dopamine Agonists therapeutic use
Humans
Levodopa therapeutic use
Monoamine Oxidase Inhibitors therapeutic use
Olfaction Disorders drug therapy
Pain drug therapy
Psychotic Disorders drug therapy
Sleep Wake Disorders drug therapy
Time Factors
Antiparkinson Agents therapeutic use
Neuroprotective Agents therapeutic use
Parkinson Disease drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1421-9913
- Volume :
- 61
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- European neurology
- Publication Type :
- Academic Journal
- Accession number :
- 19176961
- Full Text :
- https://doi.org/10.1159/000197104